174 related articles for article (PubMed ID: 37108443)
21. Effect of delay between tissue harvest and glutaraldehyde pretreatment on mineralization of bovine pericardium used in bioprosthetic heart valves.
Maranto AR; Schoen FJ
J Biomed Mater Res; 1988 Sep; 22(9):819-25. PubMed ID: 3146571
[TBL] [Abstract][Full Text] [Related]
22. Oral Use of Phenytoin to Reduce Calcification in Bovine Pericardium and Porcine Aortic Leaflets Implants in Rats.
Arruda MB; Aguiar LD; Marques SRB; Cavalcanti LRP; Sá MPBO
Braz J Cardiovasc Surg; 2021 Jun; 36(3):295-300. PubMed ID: 34387971
[TBL] [Abstract][Full Text] [Related]
23. The Immune Responses and Calcification of Bioprostheses in the α1,3-Galactosyltransferase Knockout Mouse.
Sung Jeong W; Jin Kim Y; Lim HG; Jung S; Ryul Lee J
J Heart Valve Dis; 2016 Mar; 25(2):253-261. PubMed ID: 27989076
[TBL] [Abstract][Full Text] [Related]
24. Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization.
Schoen FJ; Tsao JW; Levy RJ
Am J Pathol; 1986 Apr; 123(1):134-45. PubMed ID: 2421577
[TBL] [Abstract][Full Text] [Related]
25. A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium.
Neethling WM; Hodge AJ; Clode P; Glancy R
J Cardiovasc Surg (Torino); 2006 Dec; 47(6):711-8. PubMed ID: 17043620
[TBL] [Abstract][Full Text] [Related]
26. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms.
Vyavahare N; Hirsch D; Lerner E; Baskin JZ; Schoen FJ; Bianco R; Kruth HS; Zand R; Levy RJ
Circulation; 1997 Jan; 95(2):479-88. PubMed ID: 9008467
[TBL] [Abstract][Full Text] [Related]
27. Fixation-related autolysis and bioprosthetic aortic wall calcification.
Human P; Weissenstein C; Trantina A; Zilla P
J Heart Valve Dis; 2001 Sep; 10(5):656-65. PubMed ID: 11603606
[TBL] [Abstract][Full Text] [Related]
28. Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential.
Pathak CP; Adams AK; Simpson T; Phillips RE; Moore MA
J Biomed Mater Res A; 2004 Apr; 69(1):140-4. PubMed ID: 14999761
[TBL] [Abstract][Full Text] [Related]
29. Mitigation of calcification and cytotoxicity of a glutaraldehyde-preserved bovine pericardial matrix: improved biocompatibility after extended implantation in the subcutaneous rat model.
Neethling WM; Glancy R; Hodge AJ
J Heart Valve Dis; 2010 Nov; 19(6):778-85. PubMed ID: 21214104
[TBL] [Abstract][Full Text] [Related]
30. Diamine-extended glutaraldehyde- and carbodiimide crosslinks act synergistically in mitigating bioprosthetic aortic wall calcification.
Zilla P; Bezuidenhout D; Torrianni M; Hendriks M; Human P
J Heart Valve Dis; 2005 Jul; 14(4):538-45. PubMed ID: 16116882
[TBL] [Abstract][Full Text] [Related]
31. Elastin Stabilization Through Polyphenol and Ferric Chloride Combined Treatment for the Enhancement of Bioprosthetic Heart Valve Anticalcification.
Jin W; Guo G; Chen L; Lei Y; Wang Y
Artif Organs; 2018 Nov; 42(11):1062-1069. PubMed ID: 30058211
[TBL] [Abstract][Full Text] [Related]
32. Is the dog a useful model for accelerated calcification study of cardiovascular bioprostheses?
Chanda J; Kuribayashi R; Abe T; Sekine S; Shibata Y; Yamagishi I
Artif Organs; 1997 May; 21(5):391-5. PubMed ID: 9129770
[TBL] [Abstract][Full Text] [Related]
33. Analysis of subcutaneous fluid in rats.
Wika KE; Muramoto K; Harasaki H
ASAIO J; 1997; 43(5):M405-8. PubMed ID: 9360071
[TBL] [Abstract][Full Text] [Related]
34. Ethanol inhibition of porcine bioprosthetic heart valve cusp calcification is enhanced by reduction with sodium borohydride.
Connolly JM; Alferiev I; Kronsteiner A; Lu Z; Levy RJ
J Heart Valve Dis; 2004 May; 13(3):487-93. PubMed ID: 15222297
[TBL] [Abstract][Full Text] [Related]
35. Heparin coupling in inhibition of calcification of vascular bioprostheses.
Chanda J; Kuribayashi R; Abe T
Biomaterials; 1999 Oct; 20(19):1753-7. PubMed ID: 10509185
[TBL] [Abstract][Full Text] [Related]
36. Detoxified glutaraldehyde cross-linked pericardium: tissue preservation and mineralization mitigation in a subcutaneous rat model.
Valente M; Pettenazzo E; Thiene G; Molin GM; Martignago F; De Giorgi G; Gatti AM; Giaretta A; Pasquino E; Talenti E; Rinaldi S
J Heart Valve Dis; 1998 May; 7(3):283-91. PubMed ID: 9651841
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism.
Levy RJ; Vyavahare N; Ogle M; Ashworth P; Bianco R; Schoen FJ
J Heart Valve Dis; 2003 Mar; 12(2):209-16; discussion 216. PubMed ID: 12701794
[TBL] [Abstract][Full Text] [Related]
38. The effects of cross-link density and chemistry on the calcification potential of diamine-extended glutaraldehyde-fixed bioprosthetic heart-valve materials.
Bezuidenhout D; Oosthuysen A; Human P; Weissenstein C; Zilla P
Biotechnol Appl Biochem; 2009 Nov; 54(3):133-40. PubMed ID: 19882764
[TBL] [Abstract][Full Text] [Related]
39. Elastin calcification and its prevention with aluminum chloride pretreatment.
Vyavahare N; Ogle M; Schoen FJ; Levy RJ
Am J Pathol; 1999 Sep; 155(3):973-82. PubMed ID: 10487855
[TBL] [Abstract][Full Text] [Related]
40. Prevention of porcine aortic wall calcification by acellularization: necessity for a non-glutaraldehyde-based fixation treatment.
Meuris B; Verbeken E; Flameng W
J Heart Valve Dis; 2005 May; 14(3):358-63; discussion 363-4. PubMed ID: 15974531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
